Compound Detail
CHEMBL1090921
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1090921 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HQQDIDPWJVBPCR-UHFFFAOYSA-N |
2
Targets
4
Activities
2
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
397.9
MW (Da)
4.33
ALogP
5
HBA
1
HBD
56.0
PSA (Ų)
0.72
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 4.8
IC50 2 meas. best 5.64
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 5.64 | 5.64 | 2300.0 | 1 |
| Hepatitis C virus CHEMBL379 | IC50 | 5.28 | 5.28 | 5200.0 | 1 |
| Hepatitis C virus CHEMBL379 | EC50 | 4.8 | 4.73 | 16000.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 2300.0 | nM | 5.64 | Inhibition of HCV genotype 2b NS5B polymerase deltaC21 mutant | 20363140 |
| Hepatitis C virus | IC50 | = | 5200.0 | nM | 5.28 | Inhibition of HCV genotype 1b NS5B polymerase deltaC21 mutant | 20363140 |
| Hepatitis C virus | EC50 | = | 16000.0 | nM | 4.8 | Antiviral activity against Hepatitis C virus H2B2 | 20363140 |
| Hepatitis C virus | EC50 | = | 22000.0 | nM | 4.66 | Antiviral activity against HCV infected in human HBI10A cells | 20363140 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20363140 | 10.1016/j.bmc.2010.03.024 | Hepatitis C virus | 3 |
| 20363140 | 10.1016/j.bmc.2010.03.024 | Unchecked | 2 |
| 20363140 | 10.1016/j.bmc.2010.03.024 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine